Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-05, Stock:ABBV, The news for the past five days is as follows:
2019-02-26: NEWS1: Lawmakers grill top pharma execs over high drug costs.NEWS2: Congress Grills Drugmakers: 5 Key Takeaways.NEWS3: Congress Grills Drugmakers: 5 Key Takeaways.NEWS4: [$$] CEOs From Pfizer, Merck and Others Face Senate Over Drug Pricing.NEWS5: Home Depot, Caterpillar stock declines weigh on indices.NEWS6: Why Big Pharma’s Case to Congress Comes Up Short.NEWS7: Congress Grills Drugmakers: 5 Key Takeaways.NEWS8: There Are Many Reasons to Still Like AbbVie.NEWS9: Drugmakers’ CEOs clash with senators in hearing on drug price hikes.NEWS10: Senators grills pharma execs for raising drug prices, protecting patents 'like Gollum with his ring'.NEWS11: Sen. Ron Wyden grills pharma execs for raising drug prices, protecting patents 'like Gollum with his ring'.NEWS12: [$$] Drug-Company CEOs Take the Hot Seat Before Congress.NEWS13: Senators grill pharma execs over prescription drug prices.NEWS14: Pharma execs offer Senate ideas to lower drug costs – except actually cutting prices.NEWS15: Drugmakers’ CEOs set to get grilled at Senate hearing on rising drug prices.NEWS16: It Could Be Time For This Pharma ETF.NEWS17: 3 Top Dividend Stocks With Yields Over 5%.NEWS18: 3 Top Dividend Stocks With Yields Over 5%.NEWS19: Sen. Grassley says probe of &apos;secretive&apos; drug industry pricing won&apos;t stop with drugmakers.NEWS20: Sen. Grassley says probe of 'secretive' drug industry pricing won't stop with drugmakers.NEWS21: 3 Top Dividend Stocks With Yields Over 5%.NEWS22: [$$] US drugmakers defend pricing under fire in Senate.NEWS23: [$$] Pharmaceutical Industry CEOs Face Senate Hearing on Drug Prices.
2019-02-27: NEWS1: Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS2: Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS3: Big Pharma&apos;s Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS4: The patent system ‘keeps American drug prices so high’.NEWS5: Senate panel grills pharma CEO over executive bonuses. Calls tie to sales of AbbVie blockbuster drug Humira &apos;problematic&apos;.NEWS6: Senate panel grills pharma CEO over executive bonuses. Calls tie to sales of AbbVie blockbuster drug Humira 'problematic'.NEWS7: Voyager Therapeutics, Inc. (VYGR) Q4 2018 Earnings Conference Call Transcript.NEWS8: Senators Press Drug-Company Executives Over Prices.
2019-02-28: NEWS1: These 10 New Drugs Expected In 2019 Are On The Blockbuster Track.NEWS2: Is now the time to buy Rio Tinto? How does Abbvie look here? The desk answers your questions.NEWS3: 3 Top Stocks With High Dividend Yields.NEWS4: 3 Top Stocks With High Dividend Yields.NEWS5: IYH, ABT, MDT, ABBV: Large Outflows Detected at ETF.NEWS6: IYH, ABT, MDT, ABBV: Large Outflows Detected at ETF.NEWS7: 3 Top Stocks With High Dividend Yields.NEWS8: AbbVie to Present at the Cowen Health Care Conference.NEWS9: 10 Stocks With Safe, Generous Dividends.
2019-03-01: NEWS1: Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices.NEWS2: AbbVie to Present at the Barclays Global Healthcare Conference.NEWS3: AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI™) for the Treatment of Moderate to Severe Plaque Psoriasis.
2019-03-04: NEWS1: Here's Why Voyager Therapeutics Stock Rose as Much as 13% Today.NEWS2: Here's Why Voyager Therapeutics Stock Rose as Much as 13% Today.NEWS3: Top Research Reports for Intel, AbbVie & United Technologies.NEWS4: AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab.NEWS5: AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab.NEWS6: AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab.NEWS7: This Is Why TG Therapeutics Stock Soared 65.9% in February.NEWS8: This Is Why TG Therapeutics Stock Soared 65.9% in February.

Answer: Decrease